The London Sleep Clinic Limited
Unaudited Financial Statements
For the year ended 30 April 2025
Pages for Filing with Registrar
Company Registration No. 05095336 (England and Wales)
The London Sleep Clinic Limited
Company Information
Director
Dr I Ebrahim
Company number
05095336
Registered office
6th Floor
9 Appold Street
London
EC2A 2AP
Accountants
Moore Kingston Smith LLP
6th Floor
9 Appold Street
London
EC2A 2AP
United Kingdom
The London Sleep Clinic Limited
Contents
Page
Balance sheet
1
Notes to the financial statements
2 - 3
The London Sleep Clinic Limited
Balance Sheet
As at 30 April 2025
Page 1
2025
2024
Notes
£
£
£
£
Current assets
Debtors
3
1
1
Net current assets
1
1
Capital and reserves
Called up share capital
4
1
1

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 April 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 7 January 2026
Dr I Ebrahim
Director
Company Registration No. 05095336
The London Sleep Clinic Limited
Notes to the Financial Statements
For the year ended 30 April 2025
Page 2
1
Accounting policies
Company information

The London Sleep Clinic Limited is a private company limited by shares incorporated in England and Wales. The registered office is 6th Floor, 9 Appold Street, London, EC2A 2AP.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Profit and loss account

The company has not traded during the year or the preceding financial period. During this time, the company received no income and incurred no expenditure and therefore no Profit and loss account is presented in these financial statements.

1.3
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

1.4
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was nil (2024 - nil).

The London Sleep Clinic Limited
Notes to the Financial Statements (Continued)
For the year ended 30 April 2025
Page 3
3
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
1
1
4
Called up share capital
2025
2024
Ordinary share capital
£
£
Issued
Ordinary Shares of £1 each
1
1

Ordinary share capital of £1 is unpaid at 30th April 2025.

2025-04-30 2024-05-01 false false true CCH Software CCH Accounts Production 2025.300 No description of principal activity Dr I Ebrahim 0 05095336 2024-05-01 2025-04-30 05095336 bus:Director1 2024-05-01 2025-04-30 05095336 bus:RegisteredOffice 2024-05-01 2025-04-30 05095336 2025-04-30 05095336 2024-04-30 05095336 core:ShareCapital 2025-04-30 05095336 core:ShareCapital 2024-04-30 05095336 core:ShareCapitalOrdinaryShareClass1 2025-04-30 05095336 core:ShareCapitalOrdinaryShareClass1 2024-04-30 05095336 bus:OrdinaryShareClass1 2024-05-01 2025-04-30 05095336 bus:EntityHasNeverTraded 2024-05-01 2025-04-30 05095336 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 05095336 bus:FRS102 2024-05-01 2025-04-30 05095336 bus:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 05095336 bus:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 05095336 bus:FullAccounts 2024-05-01 2025-04-30 xbrli:pure xbrli:shares iso4217:GBP